MET and prostate cancer: In addition, HVS substantially impaired c-Met-mediated scattering phenotype of DU145 prostate cancer cells in a dose-responsive fashion, while similar treatment doses did not affect EGF-mediated cell scattering, confirming a direct inhibition of the HGF/c-Met signaling pathway (Figure 5C).